Interacting Drugs |
Bacitracin and polymyxin B vs Neuromuscular-Blocking Agents |
Security Level |
 |
Mechanism |
Neuromuscular-Blocking Agents: Polymyxin B may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents. |
Management |
Consider therapy modification |
Bacitracin and polymyxin B vs Neuromuscular-Blocking Agents
Post Review about Bacitracin and polymyxin B vs Neuromuscular-Blocking Agents Click here to cancel reply.
Other Interactions of Bacitracin and polymyxin B
Other Interactions of Neuromuscular-Blocking Agents
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.